Zami Aberman, CEO & Chairman at PLURISTEM THERAPEUTICS INC (PSTI), bought 15,000 shares at $1.07 ($16K) on 2016-02-16, disclosed to the SEC on 2016-02-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.06 | 6,000 | $6K | 39.8% |
| 2 | $1.07 | 9,000 | $10K | 60.2% |
| Total | $1.07 avg | 15,000 | $16K | 100% |
| Filing → |
| PSTI | BUY | 2019-04-08 | $100K | — | Filing → |
| PSTI | BUY | 2016-02-24 | $7K | — | Filing → |
| PSTI | BUY | 2016-02-16 | $25K | — | Filing → |